Global Point of Care Testing for Rheumatoid Arthritis Market Research Report - Segmentation by Test Type (Rheumatoid Arthritis Severity Tests, Serological Tests, Imaging Tests), By Technology (Immunoassays, Biosensors, Dipsticks, Molecular Diagnostics, Others); By End-Use (Hospitals, Diagnostic Centers, Research Laboratories, Home Care, Others); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-15622
Format:
Region: Global
Chapter 1. Global Point of Care for Rheumatoid Arthritis Market– Scope & Methodology
1.1. Market Segmentation
1.2. Scope, Assumptions & Limitations
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. Global Point of Care for Rheumatoid Arthritis Market – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.2.1. Demand Side
2.2.2. Supply Side
2.4. Attractive Investment Propositions
2.5. COVID-19 Impact Analysis
Chapter 3. Global Point of Care for Rheumatoid Arthritis Market– Competition Scenario
3.1. Market Share Analysis & Company Benchmarking
3.2. Competitive Strategy & Development Scenario
3.3. Competitive Pricing Analysis
3.4. Supplier-Distributor Analysis
Chapter 4. Global Point of Care for Rheumatoid Arthritis Market - Entry Scenario
4.1. Regulatory Scenario
4.2. Case Studies – Key Start-ups
4.3. Customer Analysis
4.5. PESTLE Analysis
4.4. Porters Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. Global Point of Care for Rheumatoid Arthritis Market- Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. Global Point of Care for Rheumatoid Arthritis Market– By Test Type
6.1. Introduction/Key Findings
6.2. Rheumatoid Arthritis Severity Tests
6.3. Serological Tests
6.4. Imaging Tests
6.5. Y-O-Y Growth trend Analysis By Test Type
6.6. Absolute $ Opportunity Analysis By Test Type, 2023-2030
Chapter 7. Global Point of Care for Rheumatoid Arthritis Market– By End–Use
7.1. Introduction/Key Findings
7.2. Hospitals & Clinics
7.3. Diagnostic Centers
7.4. Research Laboratories
7.5. Home Care
7.6. Others
7.7. Y-O-Y Growth trend Analysis By End–Use
7.8. Absolute $ Opportunity Analysis By End–Use, 2023-2030
Chapter 8. Global Point of Care for Rheumatoid Arthritis Market– By Technology
8.1. Introduction/Key Findings
8.2. Immunoassays
8.3. Biosensors
8.4. Dipsticks
8.5. Molecular Diagnostics
8.6. Others
8.7. Y-O-Y Growth trend Analysis Technology
8.8. Absolute $ Opportunity Analysis Technology, 2023-2030
Chapter 9. Global Point of Care for Rheumatoid Arthritis Market, By Geography – Market Size, Forecast, Trends & Insights
9.1. North America
9.1.1. By Country
9.1.1.1. U.S.A.
9.1.1.2. Canada
9.1.1.3. Mexico
9.1.2. By Test Type
9.1.3. By Technology
9.1.4. By End-Use
9.1.5. Countries & Segments - Market Attractiveness Analysis
9.2. Europe
9.2.1. By Country
9.2.1.1. U.K.
9.2.1.2. Germany
9.2.1.3. France
9.2.1.4. Italy
9.2.1.5. Spain
9.2.1.6. Rest of Europe
9.2.2. By Test Type
9.2.3. By Technology
9.2.4. By End-Use
9.2.5. Countries & Segments - Market Attractiveness Analysis
9.3. Asia Pacific
9.3.1. By Country
9.3.1.1. China
9.3.1.2. Japan
9.3.1.3. South Korea
9.3.1.4. India
9.3.1.5. Australia & New Zealand
9.3.1.6. Rest of Asia-Pacific
9.3.2. By Test Type
9.3.3. By Technology
9.3.4. By End-Use
9.3.5. Countries & Segments - Market Attractiveness Analysis
9.4. South America
9.4.1. By Country
9.4.1.1. Brazil
9.4.1.2. Argentina
9.4.1.3. Colombia
9.4.1.4. Chile
9.4.1.5. Rest of South America
9.4.2. By Test Type
9.4.3. By Technology
9.4.4. By End-Use
9.4.5. Countries & Segments - Market Attractiveness Analysis
9.5. Middle East & Africa
9.5.1. By Country
9.5.1.1. United Arab Emirates (UAE)
9.5.1.2. Saudi Arabia
9.5.1.3. Qatar
9.5.1.4. Israel
9.5.1.5. South Africa
9.5.1.6. Nigeria
9.5.1.7. Kenya
9.5.1.8. Egypt
9.5.1.9. Rest of MEA
9.5.2. By Test Type
9.5.3. By Technology
9.5.4. By End-Use
9.5.5. Countries & Segments - Market Attractiveness Analysis
Chapter 10. Global Point of Care for Rheumatoid Arthritis Market– Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
10.1. Abbott Diagnostics
10.2. F. Hoffman-la Roche Ltd.
10.3. Seimens AG
10.4. Augurex Life Science Corp.
10.5. Sysmex Corporation
10.6. Thermo Fisher Scientific Inc.
10.7. Beckman Coulter Inc.
10.8. Labcorp
10.9. Qiagen
10.10. Novo Integrated Science Inc
Download Sample
Choose License Type
2500
4250
5250
6900
Frequently Asked Questions
Global Point of Care Testing for Rheumatoid Arthritis Market is estimated to be USD 1.2 Billion in 2022 and is estimated to reach a value of USD 2.05 Billion by 2030, growing at a CAGR of 6.5 % during the forecast period of 2023 – 2030.
. The increase in rheumatoid arthritis among the geriatric population and research and innovation in Point of Care Testing technology are the market drivers
. Based on Technology, the Global Point of Care Testing for Rheumatoid Arthritis Market is segmented into Immunoassays, Biosensors, Dipsticks, Molecular Diagnostics, and others.
The United States of America is the most dominant country in the region of North America for Point of Care Testing for Rheumatoid Arthritis
Abbott Diagnostics, F. Hoffman-la Roche Ltd., Seimens AG, Augurex Life Science Corp., Sysmex Corporation, Thermo Fisher Scientific Inc., Beckman Coulter Inc., Labcorp, Qiagen, Novo Integrated Science Inc.
